Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Clinical Nuclear Medicine|February 17, 2025
Prognostic Value of 18 F-FDG PET in Primary Central Nervous System Lymphoma : Assessing Interim Metabolic Response for Improving Patient StratificationGa-Young Song, Ho Cheol Jang, Mihee Kim, et al.
Cellular & Molecular Immunology|March 23, 2011
Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonistsThanh-Nhan Nguyen-Pham, Mi-Seon Lim, Truc Anh Thi Nguyen, et al.
The Korean Journal of Internal Medicine|June 19, 2023
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II studyDong Won Baek, Han-Seung Park, Sang Kyun Sohn, et al.
Frontiers in Oncology|February 14, 2024
Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort studySuhyeon Kim, Jiye Jung, Seo-Yeon Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of LymphomaShin Young Hyun, June-Won Cheong, Soo-Jeong Kim, et al.
In Vivo (Athens, Greece)|July 2, 2020
Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell LymphomaDong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, et al.
BMC Cancer|April 17, 2015
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphomaSung-Hoon Jung, Jae-Sook Ahn, Yeo-Kyeoung Kim, et al.
International Journal of Hematology|March 21, 2014
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromesYundeok Kim, In-Ho Kim, Hyeong Joon Kim, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cellsVan-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Leukemia Research|May 24, 2022
Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasmsTaeHyung Kim, Jae-Sook Ahn, Meong Hi Son, et al.
Pageof 16